 cerebral amyloid plaques, appears to play a central role in the neuropathology of Alzheimer's disease (AD). Compounds that prevent the formation of Ab aggregates or that selectively destroy these aggregates are attractive candidates for the development of therapeutic reagents for prevention and treatment of Alzheimer's disease. Also, compounds that interfere with the interactions of amyloid
cerebral amyloid plaques, appears to play a central function in the neuropathology of Alzheimer's disease (AD). compound that prevent the formation of Ab aggregates or that selectively destroy these aggregate are attractive candidates for the development of curative reagents for prevention and treatment of Alzheimer's disease. Also, intensify that interfere with the interactions of amyloid
 cegebral amyloid plaques, akpears to play a ewntral role jn the nduropathology of Alzheimer's viseqse (AE). Compounds that prevevt the fogmation od Ab qggregates or that selecflvely vestroy these angregates ase attractive wavdndates for the development of therapqutic rrahents for prevgntiom and nrtatment of Alzheimer's disease. Alsk, compolnds that interfete with the interactions ov amjloid
cerebral amyloid plaques, appears to play a in neuropathology of disease (AD). Compounds Ab or that selectively these aggregates are candidates for the development of therapeutic for prevention and treatment of Alzheimer's disease. Also, compounds that interfere with the of amyloid
 cerebral amyloid plaques, appEars to play A centRal RolE iN the NeurOpathology of AlZHeimEr's disease (AD). Compounds tHat prEvENt thE FoRmatiOn of Ab aGGrEGAteS oR tHat SeLEcTivelY deStroy thEse aggregaTes ArE attractive cANdIdates for tHe dEvelopment of TheRapeutIc ReaGEnts fOr pRevenTion anD TreatmEnt of AlzhEiMEr's disEAse. Also, COMpOundS that interfere witH ThE Interactions of AmyloiD
 cerebral amyloid plaques,  appears t o pla y a  ce nt ralrole  in the neurop a thol ogy of Alzheimer's dis ease(A D ). C o mp ounds  that p r ev e n t t he  f orm at i on  of A b a ggregat es or that  se le ctively dest r oy  these agg reg ates are att rac tive c an did a tes f orthe d evelop m ent of  therapeu ti c  reage n ts forp r ev enti on and treatmento fA lzheimer's dis ease.Al s o, c omp oun ds that in te rfere with th e  i n t e rac t ions of amylo id
 cerebral_amyloid plaques,_appears to play a_central role_in_the neuropathology_of_Alzheimer's disease (AD)._Compounds that prevent_the formation of Ab_aggregates or that_selectively_destroy these aggregates are attractive candidates for the development of therapeutic reagents for prevention_and_treatment of_Alzheimer's_disease._Also, compounds that interfere with_the interactions of amyloid